{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:11:21Z","timestamp":1790673081143,"version":"4.1.0"},"reference-count":64,"publisher":"American Society of Hematology","issue":"6","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2016,2,11]]},"abstract":"<jats:title>Key Points<\/jats:title>\n               <jats:p>Acquisition of the KIT D816V mutation in an early pluripotent progenitor cell confers ISM cases a greater risk for disease progression. Despite the early acquisition of the KIT mutation, onset of clinical symptoms of ISM is often delayed to middle adulthood.<\/jats:p>","DOI":"10.1182\/blood-2015-07-655100","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T04:15:00Z","timestamp":1448943300000},"page":"761-768","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":37,"title":["KIT D816V\u2013mutated bone marrow mesenchymal stem cells in indolent systemic mastocytosis are associated with disease progression"],"prefix":"10.1182","volume":"127","author":[{"given":"Andres C.","family":"Garcia-Montero","sequence":"first","affiliation":[{"name":"Servicio General de Citometr\u00eda (NUCLEUS) and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Jara-Acevedo","sequence":"additional","affiliation":[{"name":"Servicio de Secuenciaci\u00f3n de ADN, Centro de Investigaci\u00f3n del C\u00e1ncer (Instituto de Biolog\u00eda Molecular y Celular del Cancer\u2013Consejo Superior de Investigaciones Cient\u00edficas [IBMCC-CSIC]\/Universidad de Salamanca [USAL] and Institute of Biomedical Research of Salamanca [IBSAL]) and Departamento de Medicina, Universidad de Salamanca, Salamanca, Spain;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Alvarez-Twose","sequence":"additional","affiliation":[{"name":"Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Teodosio","sequence":"additional","affiliation":[{"name":"Department of Immunology, Erasmus MC, University Medical Center Rotterdam, Rotterdam, The Netherlands"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Sanchez-Mu\u00f1oz","sequence":"additional","affiliation":[{"name":"Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Mu\u00f1iz","sequence":"additional","affiliation":[{"name":"Servicio General de Citometr\u00eda (NUCLEUS) and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier I.","family":"Mu\u00f1oz-Gonzalez","sequence":"additional","affiliation":[{"name":"Servicio General de Citometr\u00eda (NUCLEUS) and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mayado","sequence":"additional","affiliation":[{"name":"Servicio General de Citometr\u00eda (NUCLEUS) and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Almudena","family":"Matito","sequence":"additional","affiliation":[{"name":"Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Caldas","sequence":"additional","affiliation":[{"name":"Servicio General de Citometr\u00eda (NUCLEUS) and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose M.","family":"Morgado","sequence":"additional","affiliation":[{"name":"Instituto de Estudios de Mastocitosis de Castilla La Mancha (CLMast), Hospital Virgen del Valle, Toledo, Spain; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luis","family":"Escribano","sequence":"additional","affiliation":[{"name":"Servicio General de Citometr\u00eda (NUCLEUS) and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Orfao","sequence":"additional","affiliation":[{"name":"Servicio General de Citometr\u00eda (NUCLEUS) and"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"issue":"23","key":"2019111907042763900_B1","doi-asserted-by":"crossref","first-page":"10560","DOI":"10.1073\/pnas.92.23.10560","article-title":"Identification of a point mutation in the catalytic domain of the protooncogene c-kit in peripheral blood mononuclear cells of patients who have mastocytosis with an associated hematologic disorder.","volume":"92","author":"Nagata","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"issue":"1","key":"2019111907042763900_B2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2141.2007.06619.x","article-title":"Recent advances in the understanding of mastocytosis: the role of KIT mutations.","volume":"138","author":"Orfao","year":"2007","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111907042763900_B3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1038\/leu.2015.24","article-title":"KIT mutation analysis in mast cell neoplasms: recommendations of the European Competence Network on Mastocytosis.","volume":"29","author":"Arock","year":"2015","journal-title":"Leukemia"},{"issue":"7","key":"2019111907042763900_B4","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1182\/blood-2006-04-015545","article-title":"KIT mutation in mast cells and other bone marrow hematopoietic cell lineages in systemic mast cell disorders: a prospective study of the Spanish Network on Mastocytosis (REMA) in a series of 113 patients.","volume":"108","author":"Garcia-Montero","year":"2006","journal-title":"Blood"},{"issue":"7","key":"2019111907042763900_B5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0145-2126(01)00046-7","article-title":"Mastocytosis: molecular mechanisms and clinical disease heterogeneity.","volume":"25","author":"Metcalfe","year":"2001","journal-title":"Leuk Res"},{"issue":"2","key":"2019111907042763900_B6","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1097\/MOH.0b013e3283366c59","article-title":"Systemic mastocytosis in adults: a review on prognosis and treatment based on 342 Mayo Clinic patients and current literature.","volume":"17","author":"Pardanani","year":"2010","journal-title":"Curr Opin Hematol"},{"issue":"3","key":"2019111907042763900_B7","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/j.jaci.2009.05.003","article-title":"Prognosis in adult indolent systemic mastocytosis: a long-term study of the Spanish Network on Mastocytosis in a series of 145 patients.","volume":"124","author":"Escribano","year":"2009","journal-title":"J Allergy Clin Immunol"},{"issue":"13","key":"2019111907042763900_B8","doi-asserted-by":"crossref","first-page":"2393","DOI":"10.1182\/blood-2012-09-458521","article-title":"International Working Group-Myeloproliferative Neoplasms Research and Treatment (IWG-MRT) & European Competence Network on Mastocytosis (ECNM) consensus response criteria in advanced systemic mastocytosis.","volume":"121","author":"Gotlib","year":"2013","journal-title":"Blood"},{"issue":"14","key":"2019111907042763900_B9","doi-asserted-by":"crossref","first-page":"2460","DOI":"10.1182\/blood-2013-04-496448","article-title":"Comprehensive mutational profiling in advanced systemic mastocytosis.","volume":"122","author":"Schwaab","year":"2013","journal-title":"Blood"},{"issue":"3","key":"2019111907042763900_B10","doi-asserted-by":"crossref","first-page":"417","DOI":"10.3324\/haematol.2013.098442","article-title":"Co-operating STAT5 and AKT signaling pathways in chronic myeloid leukemia and mastocytosis: possible new targets of therapy.","volume":"99","author":"Bibi","year":"2014","journal-title":"Haematologica"},{"issue":"3","key":"2019111907042763900_B11","doi-asserted-by":"crossref","first-page":"459","DOI":"10.3324\/haematol.2010.031690","article-title":"Clonal analysis of NRAS activating mutations in KIT-D816V systemic mastocytosis.","volume":"96","author":"Wilson","year":"2011","journal-title":"Haematologica"},{"issue":"2","key":"2019111907042763900_B12","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1182\/blood-2002-01-0203","article-title":"Evidence for the involvement of a hematopoietic progenitor cell in systemic mastocytosis from single-cell analysis of mutations in the c-kit gene.","volume":"100","author":"Yavuz","year":"2002","journal-title":"Blood"},{"issue":"10","key":"2019111907042763900_B13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/S0145-2126(03)00065-1","article-title":"Eosinophils are derived from the neoplastic clone in patients with systemic mastocytosis and eosinophilia.","volume":"27","author":"Pardanani","year":"2003","journal-title":"Leuk Res"},{"issue":"4","key":"2019111907042763900_B14","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s002770050439","article-title":"Multilineage involvement and erythropoietin-\u201cindependent\u201d erythroid progenitor cells in a patient with systemic mastocytosis.","volume":"77","author":"Afonja","year":"1998","journal-title":"Ann Hematol"},{"issue":"2","key":"2019111907042763900_B15","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0301-472X(99)00145-9","article-title":"Analysis of the surface expression of c-kit and occurrence of the c-kit Asp816Val activating mutation in T cells, B cells, and myelomonocytic cells in patients with mastocytosis.","volume":"28","author":"Akin","year":"2000","journal-title":"Exp Hematol"},{"issue":"4","key":"2019111907042763900_B16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1016\/S1525-1578(10)60529-6","article-title":"Demonstration that mast cells, T cells, and B cells bearing the activating kit mutation D816V occur in clusters within the marrow of patients with mastocytosis.","volume":"6","author":"Taylor","year":"2004","journal-title":"J Mol Diagn"},{"issue":"44","key":"2019111907042763900_B17","doi-asserted-by":"crossref","first-page":"5139","DOI":"10.1038\/onc.2013.520","article-title":"Stem cell origin of myelodysplastic syndromes.","volume":"33","author":"Elias","year":"2014","journal-title":"Oncogene"},{"issue":"8","key":"2019111907042763900_B18","doi-asserted-by":"crossref","first-page":"3005","DOI":"10.1182\/blood-2007-03-079368","article-title":"The molecular signature of MDS stem cells supports a stem-cell origin of 5q myelodysplastic syndromes.","volume":"110","author":"Nilsson","year":"2007","journal-title":"Blood"},{"issue":"4","key":"2019111907042763900_B19","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1111\/j.1365-2141.1993.tb04695.x","article-title":"Clonality in myelodysplastic syndromes: demonstration of pluripotent stem cell origin using X-linked restriction fragment length polymorphisms.","volume":"83","author":"Tsukamoto","year":"1993","journal-title":"Br J Haematol"},{"issue":"6","key":"2019111907042763900_B20","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1093\/ajcp\/112.6.819","article-title":"Evidence for early hematopoietic progenitor cell involvement in acute promyelocytic leukemia.","volume":"112","author":"Edwards","year":"1999","journal-title":"Am J Clin Pathol"},{"issue":"8","key":"2019111907042763900_B21","doi-asserted-by":"crossref","first-page":"2906","DOI":"10.1182\/blood.V86.8.2906.2906","article-title":"Evidence for malignant transformation in acute myeloid leukemia at the level of early hematopoietic stem cells by cytogenetic analysis of CD34+ subpopulations.","volume":"86","author":"Haase","year":"1995","journal-title":"Blood"},{"issue":"7","key":"2019111907042763900_B22","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0145-2126(01)00038-8","article-title":"Diagnostic criteria and classification of mastocytosis: a consensus proposal.","volume":"25","author":"Valent","year":"2001","journal-title":"Leuk Res"},{"issue":"5","key":"2019111907042763900_B23","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/path.2677","article-title":"Variable presence of KITD816V in clonal haematological non-mast cell lineage diseases associated with systemic mastocytosis (SM-AHNMD).","volume":"220","author":"Sotlar","year":"2010","journal-title":"J Pathol"},{"issue":"5","key":"2019111907042763900_B24","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/leu.2015.4","article-title":"Molecular profiling of myeloid progenitor cells in multi-mutated advanced systemic mastocytosis identifies KIT D816V as a distinct and late event.","volume":"29","author":"Jawhar","year":"2015","journal-title":"Leukemia"},{"issue":"4","key":"2019111907042763900_B25","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.jaci.2012.12.674","article-title":"Gene expression profile of highly purified bone marrow mast cells in systemic mastocytosis.","volume":"131","author":"Teodosio","year":"2013","journal-title":"J Allergy Clin Immunol"},{"issue":"3","key":"2019111907042763900_B26","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0002-9440(10)63442-6","article-title":"Expression of Bcl-2 and Bcl-xL in cutaneous and bone marrow lesions of mastocytosis.","volume":"163","author":"Hartmann","year":"2003","journal-title":"Am J Pathol"},{"issue":"12","key":"2019111907042763900_B27","first-page":"1525","article-title":"Altered apoptosis and cell cycling of mast cells in bone marrow lesions of patients with systemic mastocytosis.","volume":"89","author":"Baldus","year":"2004","journal-title":"Haematologica"},{"issue":"5411","key":"2019111907042763900_B28","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1126\/science.284.5411.143","article-title":"Multilineage potential of adult human mesenchymal stem cells.","volume":"284","author":"Pittenger","year":"1999","journal-title":"Science"},{"issue":"4","key":"2019111907042763900_B29","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1038\/leu.2014.346","article-title":"A novel view of the adult bone marrow stem cell hierarchy and stem cell trafficking.","volume":"29","author":"Ratajczak","year":"2015","journal-title":"Leukemia"},{"issue":"9","key":"2019111907042763900_B30","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.4161\/cc.10.9.15345","article-title":"Endothelial origin of mesenchymal stem cells.","volume":"10","author":"Slukvin","year":"2011","journal-title":"Cell Cycle"},{"issue":"3","key":"2019111907042763900_B31","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1002\/ajh.23626","article-title":"Involvement of primary mesenchymal precursors and hematopoietic bone marrow cells from chronic myeloid leukemia patients by BCR-ABL1 fusion gene.","volume":"89","author":"Chandia","year":"2014","journal-title":"Am J Hematol"},{"issue":"7","key":"2019111907042763900_B32","doi-asserted-by":"crossref","first-page":"2733","DOI":"10.1182\/blood-2004-07-2514","article-title":"Identification of human chronic myelogenous leukemia progenitor cells with hemangioblastic characteristics.","volume":"105","author":"Fang","year":"2005","journal-title":"Blood"},{"issue":"2","key":"2019111907042763900_B33","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2174\/157488811795495422","article-title":"Biologic characteristics of bone marrow mesenchymal stem cells in myelodysplastic syndromes.","volume":"6","author":"Kastrinaki","year":"2011","journal-title":"Curr Stem Cell Res Ther"},{"key":"2019111907042763900_B34","doi-asserted-by":"crossref","first-page":"139","DOI":"10.2741\/4200","article-title":"Heterogeneity of mesenchymal stromal cells in lymphoproliferative disorders.","volume":"19","author":"Campioni","year":"2014","journal-title":"Front Biosci (Landmark Ed)"},{"key":"2019111907042763900_B35","article-title":"Mastocytosis.","author":"Horny"},{"issue":"10","key":"2019111907042763900_B36","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1111\/all.12436","article-title":"Proposed diagnostic algorithm for patients with suspected mastocytosis: a proposal of the European Competence Network on Mastocytosis.","volume":"69","author":"Valent","year":"2014","journal-title":"Allergy"},{"issue":"5","key":"2019111907042763900_B37","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1038\/leu.2011.293","article-title":"An immature immunophenotype of bone marrow mast cells predicts for multilineage D816V KIT mutation in systemic mastocytosis.","volume":"26","author":"Teodosio","year":"2012","journal-title":"Leukemia"},{"issue":"5","key":"2019111907042763900_B38","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1353\/hub.2002.0055","article-title":"Comparison of populations as a function of confidence intervals of gene probability.","volume":"74","author":"Sanchez","year":"2002","journal-title":"Hum Biol"},{"issue":"1","key":"2019111907042763900_B39","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s13287-015-0152-8","article-title":"Ex vivo identification and characterization of a population of CD13(high) CD105(+) CD45(-) mesenchymal stem cells in human bone marrow.","volume":"6","author":"Mu\u00f1iz","year":"2015","journal-title":"Stem Cell Res Ther"},{"issue":"4","key":"2019111907042763900_B40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1080\/14653240600855905","article-title":"Minimal criteria for defining multipotent mesenchymal stromal cells. The International Society for Cellular Therapy position statement.","volume":"8","author":"Dominici","year":"2006","journal-title":"Cytotherapy"},{"issue":"12","key":"2019111907042763900_B41","doi-asserted-by":"crossref","first-page":"3349","DOI":"10.1002\/art.10696","article-title":"Isolation and characterization of bone marrow multipotential mesenchymal progenitor cells.","volume":"46","author":"Jones","year":"2002","journal-title":"Arthritis Rheum"},{"issue":"2","key":"2019111907042763900_B42","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1016\/j.jmoldx.2010.10.004","article-title":"Improved detection of the KIT D816V mutation in patients with systemic mastocytosis using a quantitative and highly sensitive real-time qPCR assay.","volume":"13","author":"Kristensen","year":"2011","journal-title":"J Mol Diagn"},{"issue":"3","key":"2019111907042763900_B43","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1006\/mcpr.1997.0099","article-title":"Clonal X-inactivation analysis of human tumours using the human androgen receptor gene (HUMARA) polymorphism: a non-radioactive and semiquantitative strategy applicable to fresh and archival tissue.","volume":"11","author":"Kopp","year":"1997","journal-title":"Mol Cell Probes"},{"issue":"3","key":"2019111907042763900_B44","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1038\/ng0396-312","article-title":"Somatic c-KIT activating mutation in urticaria pigmentosa and aggressive mastocytosis: establishment of clonality in a human mast cell neoplasm.","volume":"12","author":"Longley","year":"1996","journal-title":"Nat Genet"},{"issue":"8","key":"2019111907042763900_B45","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1038\/modpathol.2015.72","article-title":"Detection of the KIT D816V mutation in peripheral blood of systemic mastocytosis: diagnostic implications.","volume":"28","author":"Jara-Acevedo","year":"2015","journal-title":"Mod Pathol"},{"issue":"1","key":"2019111907042763900_B46","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1159\/000085563","article-title":"Clonality and molecular pathogenesis of mastocytosis.","volume":"114","author":"Akin","year":"2005","journal-title":"Acta Haematol"},{"issue":"7","key":"2019111907042763900_B47","first-page":"871","article-title":"FIP1L1-PDGFRA and c-kit D816V mutation-based clonality studies in systemic mast cell disease associated with eosinophilia.","volume":"89","author":"Tefferi","year":"2004","journal-title":"Haematologica"},{"issue":"6","key":"2019111907042763900_B48","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/j.jaci.2005.02.030","article-title":"Analysis of the lineage relationship between mast cells and basophils using the c-kit D816V mutation as a biologic signature.","volume":"115","author":"Kocabas","year":"2005","journal-title":"J Allergy Clin Immunol"},{"issue":"5","key":"2019111907042763900_B49","doi-asserted-by":"crossref","first-page":"1411","DOI":"10.1182\/blood-2006-09-018655","article-title":"X-linked clonality testing: interpretation and limitations.","volume":"110","author":"Chen","year":"2007","journal-title":"Blood"},{"issue":"2","key":"2019111907042763900_B50","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1084\/jem.183.2.561","article-title":"Clonal stability of blood cell lineages indicated by X-chromosomal transcriptional polymorphism.","volume":"183","author":"Prchal","year":"1996","journal-title":"J Exp Med"},{"issue":"14","key":"2019111907042763900_B51","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1007\/s00018-012-1174-3","article-title":"Reactivation of the inactive X chromosome in development and reprogramming.","volume":"70","author":"Ohhata","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"2019111907042763900_B52","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S1566-3116(08)60026-2","article-title":"H.F. Molecular and genetic studies of human X chromosome inactivation.","volume":"2","author":"Brown","year":"1993","journal-title":"Adv Dev Biol"},{"issue":"3","key":"2019111907042763900_B53","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1016\/j.jaci.2012.04.013","article-title":"Adult-onset systemic mastocytosis in monozygotic twins with KIT D816V and JAK2 V617F mutations.","volume":"130","author":"Broesby-Olsen","year":"2012","journal-title":"J Allergy Clin Immunol"},{"issue":"23","key":"2019111907042763900_B54","doi-asserted-by":"crossref","first-page":"5727","DOI":"10.1182\/blood-2009-02-205237","article-title":"Systemic mastocytosis in 342 consecutive adults: survival studies and prognostic factors.","volume":"113","author":"Lim","year":"2009","journal-title":"Blood"},{"issue":"4","key":"2019111907042763900_B55","first-page":"311","article-title":"Observations on human monocyte kinetics after pulse labeling.","volume":"5","author":"Whitelaw","year":"1972","journal-title":"Cell Tissue Kinet"},{"issue":"3","key":"2019111907042763900_B56","first-page":"271","article-title":"Myeloid colony-forming cell kinetics in man.","volume":"8","author":"Koeffler","year":"1980","journal-title":"Exp Hematol"},{"issue":"4","key":"2019111907042763900_B57","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1152\/jappl.1965.20.4.803","article-title":"Neutrophilic granulocyte kinetics in normal man.","volume":"20","author":"Alexanian","year":"1965","journal-title":"J Appl Physiol"},{"issue":"2","key":"2019111907042763900_B58","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1001\/archinte.1959.00270020052006","article-title":"Lymphocyte production and turnover.","volume":"103","author":"Perry","year":"1959","journal-title":"AMA Arch Intern Med"},{"issue":"6","key":"2019111907042763900_B59","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1038\/leu.2008.49","article-title":"The immunophenotype of different immature, myeloid and B-cell lineage-committed CD34+ hematopoietic cells allows discrimination between normal\/reactive and myelodysplastic syndrome precursors.","volume":"22","author":"Matarraz","year":"2008","journal-title":"Leukemia"},{"issue":"1","key":"2019111907042763900_B60","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.scr.2015.04.005","article-title":"Impaired function of bone marrow stromal cells in systemic mastocytosis.","volume":"15","author":"Nemeth","year":"2015","journal-title":"Stem Cell Res (Amst)"},{"issue":"6","key":"2019111907042763900_B61","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1182\/blood-2008-11-189605","article-title":"Mast cell hyperplasia, B-cell malignancy, and intestinal inflammation in mice with conditional expression of a constitutively active kit.","volume":"117","author":"Gerbaulet","year":"2011","journal-title":"Blood"},{"issue":"6","key":"2019111907042763900_B62","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1111\/all.12409","article-title":"The KIT D816V allele burden predicts survival in patients with mastocytosis and correlates with the WHO type of the disease.","volume":"69","author":"Hoermann","year":"2014","journal-title":"Allergy"},{"issue":"24","key":"2019111907042763900_B63","doi-asserted-by":"crossref","first-page":"4846","DOI":"10.1182\/blood-2011-12-397588","article-title":"In aggressive forms of mastocytosis, TET2 loss cooperates with c-KITD816V to transform mast cells.","volume":"120","author":"Soucie","year":"2012","journal-title":"Blood"},{"issue":"5","key":"2019111907042763900_B64","doi-asserted-by":"crossref","first-page":"e96209","DOI":"10.1371\/journal.pone.0096209","article-title":"Loss of function of TET2 cooperates with constitutively active KIT in murine and human models of mastocytosis.","volume":"9","author":"De Vita","year":"2014","journal-title":"PLoS One"}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/6\/761\/1394077\/761.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/127\/6\/761\/1394077\/761.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T12:08:08Z","timestamp":1574165288000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/127\/6\/761\/34972\/KIT-D816Vmutated-bone-marrow-mesenchymal-stem"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2016,2,11]]},"references-count":64,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,2,11]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2015-07-655100","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2016,2,11]]}}}